pyrroles has been researched along with piroxicam in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Anderloni, A; Bianchi Porro, G; Lazzaroni, M | 1 |
Belogi, L; Mezzadri, CM; Tubaro, E | 1 |
Goud, PS; Hegde, P; Kumar, MP; Kumar, PR; Raju, S; Reddy, GO; Reddy, VV; Sailaja, M; Sarma, MR; Suresh, T | 1 |
Chon, E; Kubicek, LN; McCartan, L; Vail, DM | 1 |
de Vos, J; de Vos, P; Noorman, E; Ramos Vega, S | 1 |
Bailey, DB; Borgatti, A; Clifford, CA; Crawford-Jakubiak, M; Cronin, KL; Gardner, HL; Gill, VL; Henry, CJ; Klein, MK; Locke, J; London, CA; Mathie, T; Northrup, NC; Pennell, ML; Phillips, B; Portela, R; Post, G; Rosenberg, MP; Ruslander, DM; Stingle, N; Thamm, DH; Vail, DM; Williams, LE; Wilson-Robles, H | 1 |
Meiser, JL; Samanta, D; Zare, RN | 1 |
Marconato, L; Rossi, F; Sabattini, S; Vascellari, M | 1 |
Ansarinejad, H; Sadeghi, M; Shabani-Nooshabadi, M | 1 |
3 trial(s) available for pyrroles and piroxicam
Article | Year |
---|---|
The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Duodenum; Endoscopy; Female; Gastric Mucosa; Glycine; Humans; Intestinal Mucosa; Male; Piroxicam; Pyrroles; Stomach | 2001 |
Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Indoles; Male; Neoplasms; Piroxicam; Protein-Tyrosine Kinases; Pyrroles | 2012 |
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.
Topics: Administration, Metronomic; Amputation, Surgical; Animals; Bone Neoplasms; Carboplatin; Cyclophosphamide; Diarrhea; Disease-Free Survival; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Indoles; Kaplan-Meier Estimate; Male; Neutropenia; Osteosarcoma; Piroxicam; Prospective Studies; Pyrroles; Regression Analysis; Treatment Outcome | 2015 |
6 other study(ies) available for pyrroles and piroxicam
Article | Year |
---|---|
Anti-inflammatory and antiplatelet effects of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Body Weight; Bone Density; Carrageenan; Dose-Response Relationship, Drug; Exudates and Transudates; Glycine; In Vitro Techniques; Indomethacin; Male; Piroxicam; Platelet Aggregation; Platelet Aggregation Inhibitors; Pleurisy; Pyrroles; Rats; Thromboxane B2 | 2001 |
Synthesis and biological evaluation of thiophene [3,2-b] pyrrole derivatives as potential anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Edema; Female; Male; Piroxicam; Pyrroles; Rats; Rats, Wistar; Structure-Activity Relationship; Thiophenes | 2004 |
Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Dog Diseases; Dogs; Drug Therapy, Combination; Frontal Sinus; Indoles; Male; Paranasal Sinus Neoplasms; Piroxicam; Pyrroles; Receptor Protein-Tyrosine Kinases | 2012 |
Polypyrrole nanoparticles for tunable, pH-sensitive and sustained drug release.
Topics: Drug Carriers; Drug Liberation; Dynamic Light Scattering; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogen-Ion Concentration; Nanoparticles; Particle Size; Piroxicam; Polymers; Pyrroles | 2015 |
The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Indoles; Mammary Neoplasms, Animal; Neoplasm Staging; Piroxicam; Pyrroles; Radiation Dose Hypofractionation; Thalidomide; Treatment Outcome | 2018 |
A nanoporous gold film sensor modified with polypyrrole/CuO nanocomposite for electrochemical determination of piroxicam and tramadole.
Topics: Electrochemical Techniques; Gold; Nanocomposites; Nanopores; Piroxicam; Polymers; Pyrroles | 2023 |